A DFT-Based QSAR and Molecular Docking Studies on Potent Anti-Colon Cancer Activity of Pyrazole Derivatives

Abel Kolawole Oyebamiji

Authors

Abel Kolawole Oyebamiji

Keywords:

pyrazole derivatives, DFT-QSAR, molecular docking

Abstract

Pyrazole derivatives have been described as a group of compounds with various biological activities including anticancer effect. Therefore, a set of twenty Pyrazole based compounds which had been previously shown to be active against human colon cancer cell (HT29) are use in the study. These compounds were optimized using Density Functional Theory (DFT) for the calculations of molecular descriptors that related the bioactivity of these compounds to their structures. The developed quantitative structure activity relation (QSAR) was validated, and it showed the reliability and acceptability of the model. The in silico simulations were carried out on the twenty Pyrazole based compounds with colon cancer cell line, HT29 (PDB ID: 2N8A) using Autodock vina software. The docked complexes were validated and enumerated based on the AutoDock Scoring function to pick out the best inhibitors based on docked Energy. The analysis of the ligand-receptor complexes showed that H-bonds played a prominent role in the binding and posed stability of the ligand in the ligandreceptor complexes. The binding free energy, ΔG calculated ranged from -6.10 kcal/mol -8.20 Kcal/mol.

Downloads

How to Cite

A DFT-Based QSAR and Molecular Docking Studies on Potent Anti-Colon Cancer Activity of Pyrazole Derivatives. (2018). Global Journal of Medical Research, 18(B2), 9-21. https://medicalresearchjournal.org/index.php/GJMR/article/view/1498

Download Citation

References

However (null) Figure 3. Structure of ctTrl1-LIG..

Lig: H receptor (2N8A) complexes showing stable conformation, as well as Van Waal interactions.

Gamal El-Din, M El-Gamal, M, Abdel Maksoud, M Yoo, K Oh, C (2016) Design, synthesis, broad-spectrum antiproliferative activity, and kinase inhibitory effect of triarlpyazole derivatives possessing arylamides or arylureas moieties. 119, 122-131.

Gibbsjb (2000) Mechanism-based target dentification and drug discovery in cancer research. 287, 1969-1971.

Ravis Panteap, Elenap (2013) Evaluation of PEG-Based Hydrogel Influence on Estrogen-Receptor-Driven Responses in MCF7 Breast Cancer Cells.

Jemala (2011) Global cancer statistics. 61(2), 69-90.

Huertas, E Goulet, E Livingston (2006) Colon cancer and apoptosis. 191, 517-526.

Fabiana Tonellotto, Anke Bergmann, Karen Abrahao, Suzana Sales De Aguiar, Marcelo Adeodato Bello, Luiz Santos Thuler (2008) Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. 15(2), 76-84.

Steink, Borowickia, Scharlaud, Schettlera, Scheuk (2012) Effects of synbiotic fermentation products on primary chemoprevention in human colon cells. 23, 777-784.

Linghui Gu, Peng Wang, Qiu Zhong, Yuxing Deng, Jiangping Xie, Fei Liu, Fan Xiao, Shilong Zheng, Yue Chen, Guangdi Wang, Ling He (2017) Copper salt-catalyzed formation of a novel series of triazole-spirodienone conjugates with potent anticancer activity. 7(16), 9412-9416.

K Kumar, Sastryn, Mishrav Polakih (2015) Colon Cancer Prevention through Probiotics: An Overview. 7, 81-092.

Demirayaks Gursoya, Capang, Erolk, Vuralk (2000) Synthesis and preliminary evaluation of new 5pyrazolinone derivatives as analgesic agents. 35, 359-364.

Om Prakash, Rajesh Kumar, Vipin Parkash (2008) Synthesis and antifungal activity of some new 3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromones. 43(2), 435-440.

Richard Storer, Claire Ashton, Anthony Baxter, Michael Hann, Clara Marr, Andrew Mason, Chi-Leung Mo, Peter Myers, Stewart Noble, Charles Penn, Niall Weir, Jacqueline Woods, Paul Coe (1999) The Synthesis and Antiviral Activity of 4-Fluoro-1-β-D-ribofuranosyl-1H-pyrazole-3-carboxamide. 18(2), 203-216.

Geninmj, C Biles, B Keiser, S Poppe, S Swaney, W Tarpley, Yagiy, D Romero (2000) Novel 1, 5-Diphenylpyrazole Nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: Lead identification and SAR of 3-and 4-substituted derivatives. 43(5), 1034-1040.

Hengmiao Cheng, Et Et Al. (2006) Synthesis and SAR of Heteroaryl‐phenyl‐substituted Pyrazole Derivatives as Highly Selective and Potent Canine COX‐2 Inhibitors.. 37(29), 2076-2080.

Adnan Bekhit, Hayam Ashour, Yasser Abdel Ghany, Alaa El-Din A. Bekhit, Azza Baraka (2008) Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents. 43(3), 456-463.

S Ei-Feky, Ei-Samiizk Abd (1996) Synthesis and antihypertensive activity of novel 1-(4-benzyl-1phthalazinyl)-pyrazolo [3,4-d] pyrimidines. 51, 540-543.

Satoru Kuroda, Atsushi Akahane, Hiromichi Itani, Shintaro Nishimura, Kieran Durkin, Takayoshi Kinoshita, Yoshiyuki Tenda, Kazuo Sakane (1999) Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-α]pyridine adenosine A1 receptor antagonist. 9(14), 1979-1984.

M Moustafa, H Zeinab, M Soad, A Anhar (2004) Antimicrobial activity of amino acid, imidazole, and sulfonamide derivatives of pyrazolo [3,4d]pyrimidine. 15(1), 57-62.

Stephen Lindell, Brian Moloney, Brian Hewitt, Christopher Earnshaw, Philip Dudfield, Jane Dancer (1999) The design and synthesis of inhibitors of adenosine 5′-monophosphate deaminase. 9(14), 1985-1990.

N Hend, El-Gazzar Abdel-Rhman, B, Al-Hussain Sami, A (2016) Novel pyrazole derivatives with oxa/ thiadiazolyl, pyrazolyl moieties and pyrazolo[4,3-d]pyrimidine derivatives as potential antimicrobial and anticancer agents.

Josef Stehlik, Matthew Movsesian (2006) Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure. 15(7), 733-742.

Pandeyasnand Raip (2012) Synthesis and Anti-Hepatitis B Virus Activity of Novel Benzimidazole Derivatives. 1(4), 1-4.

P Santosh, Pandeyasn, A Pathak (2011) Benzimidazole: a versatile chemical entity. 2(6), 1726-1737.

Hanschc (1969) Quantitative approach to biochemical structure-activity relationships. 2(8), 232-239.

C Ramsden (1990) Quantitative Drug Design of comprehensive Medicinal Chemistry. 4.

G Dahl, Jaitlyn, Salakhutdinovr Multitask Neural Networks for QSAR Predictions. 1231.

Oyebamiji Ak (2016) STUDIES OF ANTI-HYPERTENSIVE ACTIVITY OF 1, 4-DIHYDROPYRIDINE DERIVATIVES: COMBINATIONS OF DFT-QSAR AND DOCKING APPRAOCHES. 6(3), 105-113.

Semireb Oyebamijika (2016) Studies of 1, 4-Dihydropyridine Derivatives for Anti-Breast Cancer (MCF-7) Activities: Combinations of DFT-QSAR and Docking Methods. 9(6), 58-66.

A Oyebamiji, Semireb (2016) DFT-QSAR model and docking studies of anti liver cancer (HEPG-2) activities of 1, 4-diydropyridine based derivatives. 6(2), 69-72.

S Arulmozhiraja, M Morita (2004) Structure-activity relationships for the toxicity of polychhorinateddibenzofurans: approach through density functional theory-based descriptors. 17, 348-356.

Chenggang Gu, Xin Jiang, Xuehai Ju, Xuedong Gong, Fang Wang, Yongrong Bian, Cheng Sun (2009) QSARs for congener-specific toxicity of polyhalogenated dibenzo-p-dioxins with DFT and WHIM theory. 72(1), 60-70.

Erol Eroglu, Hasan Türkmen (2007) A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II. 26(4), 701-708.

Menjun Zhu, Fei Ge, Runliang Zhu, Xueye Wang, Xiaoyan Zheng (2010) A DFT-based QSAR study of the toxicity of quaternary ammonium compounds on Chlorella vulgaris. 80(1), 46-52.

A Jain (2006) Scoring functions for protein-ligand docking. 7(5), 407-420.

R Taylor, P Jewsbury, J Essex (2002) A review of protein-small molecule docking methods. 16(3), 151-166.

Beckead (1993) Density-functional thermochemistry. III. The role of exact exchange. 98(7), 5648-5652.

Yangw Leec, R Parr (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. 37, 785-789.

Perpeteea Jacquemind, Adamoc Ciofinii (2008) Accurate simulation of optical properties in dyes. 42, 326-3344.

David Whaley,, Slav Danev, Michael Alexander, Jonathan Lakey (2024) Early Detection of Peripheral Neuropathy by Assessment of Sudomotor Function. 5(1).

Goodarzim, B Dejaegher, Vander Heydeny (2012) Features selection methods in QSAR studies. 95(3), 636-651.

Eustermanns, W Wu, M Langelier, J Yang, L Easton, A Riccio, J Pascal, Neuhausd (2015) Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1. 60, 742-754.

Ajeet Sapnar, K Arvind (2014) Designing of Sulfanilamide/ Sulfacetamide Derivatives as Human Topoisomerase II Inhibitor: A Docking Approach. 2(2), 42-46.

Nicola Chirico, Paola Gramatica (2011) Real External Predictivity of QSAR Models: How To Evaluate It? Comparison of Different Validation Criteria and Proposal of Using the Concordance Correlation Coefficient. 51(9), 2320-2335.

Nicola Chirico, Paola Gramatica (2012) Real External Predictivity of QSAR Models. Part 2. New Intercomparable Thresholds for Different Validation Criteria and the Need for Scatter Plot Inspection. 52(8), 2044-2058.

P Marrero, Gja Castillo, Torrensf, Z Romero, E Castro (2004) Atom, atom-type, and total linear indices of the molecular pseudograph's atom adjacency matrix": application to QSPR/QSAR studies of organic compounds. 9(12), 1100-1123.

Arsiantia Paramitari, Radjim (2017) In Silico Docking Studies of Alkyl Esters Derivative of Gallic Acid on Bcl-xL Anti-apoptotic Protein of Breast Cancer. 10(1), 348-355.

Adejoroia, S Waheed, O Adeboye (2016) Molecular Docking Studies of Lonchocarpuscyanescens Triterpenoids as Inhibitors for Malaria. 6, 213.